Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Financing Activities: 2023-2025

Historic Cash from Financing Activities for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $760,000.

  • Upstream Bio's Cash from Financing Activities rose 146.31% to $760,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $272.0 million, marking a year-over-year increase of 83.61%. This contributed to the annual value of $418.9 million for FY2024, which is 223.36% up from last year.
  • Latest data reveals that Upstream Bio reported Cash from Financing Activities of $760,000 as of Q3 2025, which was up 24.18% from $612,000 recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Cash from Financing Activities peaked at $270.6 million during Q4 2024, and registered a low of -$1.6 million during Q3 2024.
  • In the last 3 years, Upstream Bio's Cash from Financing Activities had a median value of $686,000 in 2025 and averaged $52.5 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 203,594.74% in 2024, then tumbled by 100.36% in 2025.
  • Quarterly analysis of 3 years shows Upstream Bio's Cash from Financing Activities stood at -$133,000 in 2023, then soared by 203,594.74% to $270.6 million in 2024, then spiked by 146.31% to $760,000 in 2025.
  • Its Cash from Financing Activities stands at $760,000 for Q3 2025, versus $612,000 for Q2 2025 and -$34,000 for Q1 2025.